Illustrative certificateNS-2026-06063

Nordicstar Analytical Sciences

Thymosin Alpha-1 5 MG

99.583%HPLC purity

Lot: GLZ-26-TA1-1062
Measured content: 5.03 mg
Mass-spec identity: Confirmed
Endotoxin: <1.0 EU/mg
Tested: 17 Sep 2026

View Lab Report

Immunology

Thymosin Alpha-1

Q: What defines Thymosin Alpha-1 chemically?

It is a 28-amino-acid peptide with N-terminal acetylation. Published recombinant-production work has used mass spectrometry to confirm sequence and acetylation, which are separate analytical questions from testing any particular catalog lot.

Q: Why do cell conditions matter in this research?

In dendritic-cell experiments, reported maturation, activation markers and cytokine responses depended on the experimental environment, including the presence or absence of TNF-alpha. Results should be read with those conditions in view.

Thymic peptide identity & immune-cell signaling

$48.00USD / vialView COA

A pair saves 10%. A set of three saves 15%.

For laboratory research use only.
Not for human consumption or clinical use.

Compound details

Compound: Thymosin Alpha-1
CAS number: 62304-98-7
Molecular formula: C129H215N33O55
Molecular weight: 3108.3 g/mol
Form: Lyophilized

Quality & documentation

The records shown here are illustrative. Request laboratory-issued documentation for your lot before ordering.

Lot: GLZ-26-TA1-1062
HPLC purity: 99.583%
Measured content: 5.03 mg
Tested: 17 Sep 2026
Report: NS-2026-06063

View the 5 MG certificate

Our quality approach

Shipping & handling

Priority, tracked shipping within the United States, free on orders of $200 or more after savings. Add Priority dispatch at checkout to have your order packed first; Private Clients receive it on every order. Follow the product documentation for laboratory handling requirements.

Shipping information

Explore the research profile

Thymosin Alpha-15 MG · Single

$48.00

01 / The compound

Understand
the starting point.

Thymic peptide identity & immune-cell signaling

Thymosin Alpha-1 is a 28-amino-acid thymic peptide characterized by an acetylated N-terminus. The research literature describes the defined peptide separately from more complex thymus-derived preparations.

Its research profile centers on immune-cell differentiation, dendritic-cell biology and Toll-like-receptor-associated signaling. The cited experiments include biochemical, cultured-cell and animal systems.

02 / Research profile

The pathways.
The possibilities.

The cited dendritic-cell experiments investigate Toll-like-receptor-associated signaling, p38 MAPK, NF-κB and MyD88-dependent pathways. Peptide identity and N-terminal acetylation are established through a separate line of analytical research.

01 / Research focus

Dendritic-Cell & Toll-Like Receptor Research

Experimental research has examined Thymosin Alpha-1 in dendritic-cell systems and Toll-like-receptor-associated signaling. A 2004 study reported changes involving p38 MAPK, NF-κB and MyD88-dependent signaling in experimental dendritic-cell models. These findings provide mechanistic context for research into Thymosin Alpha-1 and immune-cell signaling. They should be interpreted within the specific cell and animal systems used in the experiments and should not be presented as evidence of a clinical effect of GLPZone material.

02 / Research focus

Dendritic-Cell Differentiation Research

Separate laboratory research using murine bone-marrow-derived dendritic cells examined Thymosin Alpha-1 in relation to dendritic-cell maturation, differentiation, activation-marker expression and cytokine responses under controlled experimental conditions. The reported responses varied according to the experimental environment, including the presence or absence of TNF-alpha. This work is useful as mechanistic laboratory evidence and should not be generalized beyond the model studied.

03 / Research focus

Peptide Identity & N-Terminal Acetylation

Thymosin Alpha-1 is a 28-amino-acid peptide characterized by N-terminal acetylation. Recombinant-production research has confirmed the peptide sequence and N-terminal acetylation using mass-spectrometry-based analytical methods. This literature provides useful structural and analytical context for the identity of Thymosin Alpha-1 but does not constitute testing of GLPZone material. Product-specific analytical information must continue to come only from the applicable lot-specific Certificate of Analysis.

Reading the evidence

Published research on Thymosin Alpha-1 spans biochemical, cell-based and animal experimental systems. Findings should be interpreted according to the compound, model, methodology and conditions used in each publication. Results from published research should not be interpreted as demonstrating therapeutic efficacy or as establishing the properties of GLPZone material.

03 / Reference data

The details,
in plain sight.

Reference specifications describe a compound. The final lot documentation identifies the material supplied.

Thymosin Alpha-1 reference specifications
Compound	Thymosin Alpha-1
Research area	Immunology
CAS number	62304-98-7
Molecular formula	C129H215N33O55
Molecular weight	3108.3 g/mol
Physical form	Lyophilized
Vial options	5 MG · 10 MG
Intended use	Laboratory research only

Variant amounts are nominal catalog quantities. They are not instructions for use.

04 / Quality & documentation

A number needs
its context.

How testing works

01 / Purity

What is in the sample?

HPLC separates components under a defined method. Read the reported percentage alongside the chromatogram, wavelength, integration method, and scope of the test.

02 / Identity

Is it the expected compound?

Mass spectrometry provides molecular-mass evidence. Identity and chromatographic purity answer different questions; one cannot stand in for the other.

03 / Traceability

Does the report match the vial?

Connect the product name, variant, lot identifier, report date, and issuing laboratory. A report is useful only when its sample can be linked to the material being reviewed.

Independent analysis

Every Thymosin Alpha-1 lot is analyzed by Nordicstar Analytical Sciences for identity, content, and purity by HPLC with LC-MS confirmation. Each certificate carries a report number and verification key that can be checked at nordicstarlabs.com/verify. Research references below describe published science, not a certificate for a vial.

Read a COA with confidence

Thymosin Alpha-1 lot certificates
Presentation	Lot	HPLC purity	Tested	Certificate
10 MG Current lot	`GLZ-26-TA1-1063`	99.697%	20 Sep 2026	NS-2026-06064
5 MG Current lot	`GLZ-26-TA1-1062`	99.583%	17 Sep 2026	NS-2026-06063
10 MG	`GLZ-26-TA1-737`	99.637%	19 Aug 2026	NS-2026-06199
5 MG	`GLZ-26-TA1-738`	99.644%	13 Aug 2026	NS-2026-06197
5 MG	`GLZ-26-TA1-638`	99.675%	16 Jul 2026	NS-2026-06198
10 MG	`GLZ-26-TA1-637`	99.678%	16 Jul 2026	NS-2026-06200

05 / Storage & handling

Care for
the material.

Keep sealed research material protected from moisture, unnecessary light and temperature fluctuations. Use the storage conditions documented for the specific compound, formulation and lot.

Solution stability depends on solvent, concentration, container and experimental conditions. Use a validated laboratory protocol; a universal post-reconstitution shelf life is not established by the literature summaries.

Explore the handling guide

06 / Common questions

A little more
understanding.

What defines Thymosin Alpha-1 chemically?

It is a 28-amino-acid peptide with N-terminal acetylation. Published recombinant-production work has used mass spectrometry to confirm sequence and acetylation, which are separate analytical questions from testing any particular catalog lot.

Why do cell conditions matter in this research?

In dendritic-cell experiments, reported maturation, activation markers and cytokine responses depended on the experimental environment, including the presence or absence of TNF-alpha. Results should be read with those conditions in view.

07 / Further reading